Cavalier Investments »

Madrigal Pharmaceuticals shares owned by Cavalier Investments

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Cavalier Investments from 13F filings

Historical chart of Cavalier Investments investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Cavalier Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Cavalier Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $773k 3.6k 212.22

More positions owned by Cavalier Investments

Eli Lilly & Co. (LLY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Communication (XLC)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard World Financials Etf (VFH)
Howmet Aerospace (HWM)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)

View all positions for Cavalier Investments

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Paulson & Co
Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Jane Street
Geode Capital Management
Artisan Partners Limited Partnership
Rock Springs Capital Management
Erste Asset Management GmbH
Morgan Stanley

View all funds holding Madrigal Pharmaceuticals